<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T18:22:41Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/175278" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/175278</identifier><datestamp>2025-12-06T01:55:10Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478809</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Chronic kidney disease in Spain: analysis of patient characteristics, incidence and direct medical costs (2011-2017)</dc:title>
   <dc:creator>Darbà, Josep</dc:creator>
   <dc:creator>Marsà, Alícia</dc:creator>
   <dc:subject>Insuficiència renal crònica</dc:subject>
   <dc:subject>Mortalitat</dc:subject>
   <dc:subject>Política sanitària</dc:subject>
   <dc:subject>Política de despeses públiques</dc:subject>
   <dc:subject>Chronic renal failure</dc:subject>
   <dc:subject>Mortality</dc:subject>
   <dc:subject>Medical policy</dc:subject>
   <dc:subject>Government spending policy</dc:subject>
   <dcterms:abstract>To review the characteristics of patients with chronic kidney disease (CKD) who attended primary and specialized care centers in Spain, and to analyze patients' use of medical resources and direct medical costs of specialized care.</dcterms:abstract>
   <dcterms:issued>2021-03-17T20:54:55Z</dcterms:issued>
   <dcterms:issued>2021-12-31T06:10:21Z</dcterms:issued>
   <dcterms:issued>2020-12</dcterms:issued>
   <dcterms:issued>2021-03-17T20:54:55Z</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
   <dc:relation>Versió postprint del document publicat a: https://doi.org/10.1080/13696998.2020.1830782</dc:relation>
   <dc:relation>Journal of Medical Economics, 2020, vol. 23, num. 12, p. 1623-1629</dc:relation>
   <dc:relation>https://doi.org/10.1080/13696998.2020.1830782</dc:relation>
   <dc:rights>(c) Taylor and Francis, 2020</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>Taylor and Francis</dc:publisher>
   <dc:source>Articles publicats en revistes (Economia)</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>